Skip to main content
Tick Boot Camp

Episode 635: Can Ozone Therapy Help Stubborn Lyme Symptoms? Dr. Lynn Klassen | LIVE from ILADS

36 minutes ago

What happens when Lyme disease patients reach a treatment plateau and continue struggling with fatigue, pain, and inflammation? Could ozone therapy offer additional support when conventional and integrative treatments have not produced the progress patients hoped for?

In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen welcomes back Dr. Lynn Klassen, ND, a naturopathic physician specializing in Lyme disease and complex chronic illness and the founder of Tandem Clinic in Vancouver, British Columbia, Canada.

Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this interview explores the potential role of ozone therapy, specifically single-pass major autohemotherapy (MAH), as an adjunctive treatment for patients with persistent symptoms.

After appearing on Tick Boot Camp during a previous ILADS conference alongside her colleague Dr. Carolyn Mukai, Dr. Klassen returns to discuss research presented at this year's conference.

Her presentation focused on a clinical case series involving patients with complex chronic illness who had reached treatment plateaus.

These patients continued experiencing symptoms such as fatigue, chronic pain, and skin-related complaints despite previous interventions.

Dr. Klassen explains why her team began exploring oxidative therapies and describes how single-pass ozone autohemotherapy is performed.

Rich guides the conversation from technical explanations toward practical questions patients want answered: What is ozone therapy? What happens during a treatment? Why might a clinician consider it? And what does the available evidence actually tell us?

This episode explores the science, theories, and clinical observations behind ozone therapy while highlighting the need for more rigorous research into its safety and effectiveness for Lyme disease.

Meet Dr. Lynn Klassen, ND

Dr. Lynn Klassen is a naturopathic physician and founder of Tandem Clinic in Vancouver, British Columbia.

Her practice focuses on Lyme disease, associated tick-borne infections, and complex chronic illness.

Dr. Klassen has been involved in practitioner education and the development of training opportunities for naturopathic physicians interested in vector-borne diseases.

She has also worked with Dr. Carolyn Mukai, ND, to expand access to specialized care and education for patients and healthcare professionals.

Her professional interests include:

  • Lyme disease and associated infections
  • Complex chronic illness
  • Integrative and naturopathic medicine
  • Adjunctive therapies
  • Practitioner education and mentorship
  • Collaborative patient care
  • Research into supportive treatment approaches

During the interview, Rich recalls meeting Dr. Klassen and Dr. Mukai at a previous ILADS conference when they were participating as exhibitors.

This year, Dr. Klassen returned as a conference speaker, presenting clinical observations involving ozone therapy.

From ILADS Exhibitor to Conference Speaker

Rich opens the interview by welcoming Dr. Klassen back to Tick Boot Camp.

The two joke about their first meeting, when Rich encouraged her and her colleague to participate in an interview.

This time, Dr. Klassen has returned to the conference in a different capacity.

Rather than exhibiting, she is presenting on the use of ozone therapy as adjunctive care for patients with complex chronic illness.

Her presentation focuses on patients whose symptoms had stopped improving despite previous treatment.

The discussion reflects a challenge familiar to many people living with persistent symptoms: reaching a point where progress becomes difficult to measure and patients and clinicians begin considering additional options.

Dr. Klassen explains that her team began exploring oxidative therapies in selected patients and presented their clinical observations as a case series.

A case series can describe patient experiences and generate research questions, but it cannot establish whether a treatment caused improvement or is effective compared with other approaches.

When Lyme Disease Patients Reach a Treatment Plateau

Dr. Klassen describes patients who continue experiencing symptoms despite undergoing treatment for complex chronic illness.

The symptoms discussed include:

  • Persistent fatigue
  • Chronic pain
  • Skin manifestations
  • Ongoing inflammatory complaints
  • Difficulty achieving further symptom improvement

She explains that these situations can prompt clinicians to reassess treatment plans and investigate additional approaches.

In her practice, one option being explored is ozone-based major autohemotherapy.

The intention is to use ozone therapy alongside other treatments rather than as a replacement for appropriate medical care.

However, persistent symptoms can have many causes, including other medical conditions, medication effects, sleep disorders, autonomic dysfunction, and complications unrelated to active infection.

A treatment plateau does not automatically indicate persistent Borrelia infection or the need for additional antimicrobial treatment.

What Is Ozone Therapy?

Ozone is a molecule composed of three oxygen atoms, represented chemically as O3.

It is a highly reactive oxidizing agent.

Ozone has recognized antimicrobial properties in certain environmental and industrial applications.

However, these properties do not establish that introducing ozone-treated blood into the body safely eliminates Lyme disease bacteria or other pathogens.

During the interview, Dr. Klassen discusses the theory that carefully controlled exposure to ozone may influence biological signaling pathways.

She describes possible effects involving:

  • Immune system regulation
  • Oxidative stress responses
  • Blood circulation
  • Oxygen delivery to tissues
  • Red blood cell function
  • Distribution of medications

These proposed mechanisms remain under investigation.

Clinical evidence has not established that ozone autohemotherapy reliably improves these functions or produces meaningful health benefits in patients with Lyme disease.

What Is Major Autohemotherapy?

One of the most educational parts of the conversation is Dr. Klassen's explanation of major autohemotherapy (MAH).

Rich asks her to explain the procedure in simple terms.

Dr. Klassen describes a process in which blood is withdrawn from a patient, exposed to a controlled ozone-oxygen gas mixture outside the body, and then reinfused.

The basic sequence she describes is:

  1. Blood is withdrawn through an intravenous line into a specialized collection system.
  2. The blood is mixed with an ozone-oxygen gas preparation.
  3. The treated blood is returned to the patient through the intravenous system.

The procedure is sometimes called ozone autohemotherapy.

Importantly, this is different from directly injecting ozone gas into a vein, which can be dangerous.

Major autohemotherapy is still an invasive procedure involving blood handling and intravenous access. It requires appropriate equipment, infection-control practices, and qualified medical oversight.

What Does One-Pass Ozone Mean?

Dr. Klassen explains that her clinical presentation focuses on single-pass ozone autohemotherapy.

A pass refers to one cycle of withdrawing blood, exposing it to an ozone-oxygen mixture, and reinfusing it.

She contrasts this with more intensive approaches sometimes described as:

  • Ten-pass ozone therapy
  • Hyperbaric ozone therapy
  • Extracorporeal blood oxygenation and ozonation (EBOO)

These procedures differ in equipment, processing methods, and treatment protocols.

Dr. Klassen emphasizes that her team is investigating a comparatively limited single-pass approach rather than the more intensive techniques.

Rich appreciates the straightforward explanation because it helps patients understand what is involved.

Although single-pass therapy may sound less complicated than multi-pass systems, it still carries procedural and biological risks.

A lower number of passes does not independently establish safety or effectiveness.

Why Dr. Klassen Is Interested in Immune Modulation

Dr. Klassen explains that one of her main interests is the possibility that ozone therapy could influence immune system activity.

She describes the immune system as having multiple functions that need to remain appropriately balanced.

During infections and inflammatory conditions, immune signaling can become dysregulated.

Dr. Klassen discusses the theory that ozone exposure may influence certain immune responses and potentially reduce excessive inflammatory activity.

She also raises the possibility that it could support other aspects of immune function.

These are proposed biological effects rather than demonstrated clinical outcomes in Lyme disease patients.

Immune regulation is complex, and a therapy cannot be assumed to selectively calm harmful immune activity while strengthening beneficial responses.

More research is necessary to determine whether ozone autohemotherapy produces reproducible, clinically meaningful immune effects.

What Does an Overactive Immune System Feel Like?

Rich asks Dr. Klassen to explain immune hyperreactivity in terms that patients can understand.

She describes people who experience heightened sensitivity to everyday exposures.

Examples discussed include:

  • Reactions to certain foods
  • Sensitivity to soaps or fragrances
  • Increased discomfort around chemical exposures
  • Fatigue
  • Feeling overstimulated
  • Other symptoms associated with inflammatory or immune-related conditions

These experiences can be particularly difficult for people managing complex chronic illness.

However, food reactions, chemical sensitivities, fatigue, and overstimulation have many possible causes.

They do not necessarily indicate immune hyperreactivity, mast cell activation syndrome, or an underlying tick-borne infection.

Appropriate evaluation is important before attributing these symptoms to a particular mechanism.

Ozone Therapy and Tissue Oxygenation

Dr. Klassen also discusses the proposed relationship between ozone autohemotherapy and oxygen delivery.

She explains that red blood cells transport oxygen throughout the body.

Her team is interested in whether ozone treatment could influence blood flow or tissue perfusion.

Tissue perfusion refers to the delivery of blood through the small blood vessels that supply tissues and organs.

Dr. Klassen suggests that changes in red blood cell behavior might theoretically influence how oxygen reaches certain tissues.

She also discusses the possibility of affecting medication distribution.

These ideas are part of the proposed rationale for the treatment.

However, the interview does not provide controlled clinical evidence demonstrating that single-pass ozone therapy improves oxygen delivery or medication effectiveness in Lyme disease patients.

The presence of a plausible biological mechanism does not establish a clinical benefit.

Can Ozone Therapy Kill Lyme Disease Bacteria?

Rich asks whether ozone could help reduce the microbial burden in patients with Lyme disease.

Dr. Klassen acknowledges ozone's antimicrobial properties and discusses the possibility of using it as part of a broader treatment approach.

Ozone can damage microorganisms under certain laboratory conditions.

However, exposing blood to ozone outside the body is not equivalent to delivering an antimicrobial treatment directly to infected tissues.

There is insufficient reliable clinical evidence demonstrating that ozone autohemotherapy eradicates Borrelia burgdorferi, Bartonella, Babesia, or other tick-borne pathogens in humans.

Ozone therapy should not be considered a proven substitute for recommended antimicrobial treatment.

Dr. Klassen's interest in the therapy is primarily focused on proposed downstream biological effects rather than direct antimicrobial activity alone.

Could Ozone Therapy Help With Fatigue and Pain?

Dr. Klassen explains that fatigue and pain were among the symptoms experienced by patients in the case series presented at ILADS.

These symptoms can have a substantial impact on quality of life.

Patients may struggle with daily activities, employment, exercise, relationships, and maintaining independence.

Her team's interest in ozone therapy arose from the desire to explore additional options for patients whose progress had stalled.

However, the transcript does not provide specific patient outcomes, numerical improvements, control groups, or follow-up data.

Therefore, the interview does not establish whether ozone therapy improved fatigue, pain, skin symptoms, or overall functioning.

The case series may help identify questions for future clinical studies.

Patients considering experimental adjunctive therapies should understand the uncertainty surrounding their effectiveness and the potential risks involved.

Understanding the Risks and Limitations of Ozone Therapy

Ozone therapy is not an FDA-approved treatment for Lyme disease.

The FDA has warned about ozone's toxic properties and the lack of established medical usefulness for conditions where safety and effectiveness have not been demonstrated.

Potential concerns with blood-based ozone procedures include:

  • Complications from intravenous access
  • Infection or contamination during blood handling
  • Damage to blood components
  • Oxidative injury
  • Problems related to equipment or administration
  • Uncertain long-term effects
  • Financial costs associated with unproven treatment

Direct exposure to ozone gas can also cause serious respiratory injury.

The risks of different ozone procedures may vary, and the available evidence is insufficient to establish a reliable safety and effectiveness profile for Lyme disease treatment.

Patients should discuss potential risks, alternatives, and the quality of supporting evidence with qualified healthcare professionals before considering an investigational procedure.

Why Research Into Adjunctive Therapies Matters

Dr. Klassen's presentation highlights an important question for clinicians working with complex chronic illness:

What additional approaches deserve scientific investigation when patients continue experiencing disabling symptoms?

Clinical observations can provide a starting point.

A clinician may notice changes in patients receiving a particular intervention and decide that those experiences warrant further study.

But determining whether a treatment actually works requires more rigorous research.

Useful studies would need to evaluate:

  • Clearly defined patient populations
  • Standardized treatment protocols
  • Measurable outcomes
  • Adverse events
  • Appropriate comparison groups
  • Follow-up over time

For ozone autohemotherapy, these steps are necessary before reliable conclusions can be drawn about its role in Lyme disease or complex chronic illness care.

The goal of research is not simply to identify new treatments but to determine which interventions genuinely help patients and which may expose them to unnecessary risks.

The Importance of Clear Patient Education

Throughout the interview, Rich repeatedly asks Dr. Klassen to translate medical terminology into language that patients and caregivers can understand.

He emphasizes that Tick Boot Camp serves people at many different stages of their journeys.

Some listeners are just beginning to investigate unexplained symptoms.

Others have recently received a Lyme disease diagnosis.

Many have been navigating chronic illness for years and are trying to understand their treatment options.

Rich wants patients to understand what a procedure involves, why it is being considered, and what outcomes are supported by evidence.

This patient-centered approach reflects Tick Boot Camp's mission of helping people feel informed, validated, and empowered.

Understanding a treatment is an essential part of making informed healthcare decisions.

Reconnecting at ILADS

The interview concludes on a warm note as Rich and Dr. Klassen reflect on reconnecting at the ILADS conference.

Rich explains that he is preparing to co-emcee an event later that evening.

He thanks Dr. Klassen for returning to Tick Boot Camp and sharing her work with the patient community.

Their conversation demonstrates the value of bringing healthcare professionals and patient advocates together to discuss emerging ideas while making complex medical topics easier to understand.

Key Takeaways From Dr. Lynn Klassen

  1. Treatment plateaus can be frustrating. Dr. Klassen discusses patients who continue experiencing fatigue, pain, and other symptoms despite previous treatment.
  2. Ozone therapy is being explored as an adjunctive approach. Her ILADS presentation focused on a clinical case series involving complex chronic illness.
  3. Major autohemotherapy involves treating withdrawn blood outside the body. The blood is exposed to an ozone-oxygen mixture before reinfusion.
  4. Single-pass ozone differs from multi-pass procedures. Dr. Klassen describes using one treatment cycle rather than more intensive approaches.
  5. Immune modulation is a proposed mechanism. Research has not established that ozone autohemotherapy reliably normalizes immune function in Lyme disease.
  6. Improved oxygen delivery remains theoretical. The interview discusses possible effects on red blood cells and tissue perfusion without demonstrating clinical benefits.
  7. Laboratory antimicrobial activity does not establish infection clearance. Ozone therapy has not been proven to eradicate tick-borne pathogens in patients.
  8. Patient symptoms deserve continued investigation. Fatigue, pain, and sensitivities can have multiple causes that require individualized evaluation.
  9. Case series generate research questions. They cannot independently establish treatment effectiveness.
  10. Safety matters. Ozone autohemotherapy is an invasive, investigational procedure with potential risks.
  11. Patient education supports informed decisions. Rich emphasizes making complicated medical topics understandable.
  12. The Lyme disease community benefits from continued research and collaboration. New ideas deserve careful scientific evaluation before becoming established treatments.

Resources Mentioned in This Episode

Dr. Lynn Klassen and Tandem Clinic

Related Tick Boot Camp Episodes and Resources

About This LIVE from ILADS Episode

Recorded at the 2025 ILADS Conference in San Antonio, Texas, this episode features Dr. Lynn Klassen, ND, founder of Tandem Clinic in Vancouver, Canada.

Returning to Tick Boot Camp after a previous conference appearance, Dr. Klassen discusses her presentation on ozone therapy as adjunctive care for complex chronic illness.

She explains single-pass major autohemotherapy, including how the procedure works and the proposed biological mechanisms involving immune regulation, oxygen delivery, and blood circulation.

The conversation also explores persistent fatigue, chronic pain, immune hyperreactivity, and the importance of evaluating experimental treatments through rigorous clinical research.

For patients navigating persistent symptoms, this conversation offers an opportunity to better understand an emerging treatment approach, ask informed questions, and recognize the importance of balancing hope with reliable medical evidence.